Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells

Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administration of escalating cell doses improves the efficac...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Bremm, Melanie, Pfeffermann, Lisa-Marie, Cappel, Claudia, Katzki, Verena, Erben, Stephanie, Betz, Sibille, Quaiser, Andrea, Merker, Michael, Bonig, Halvard, Schmidt, Michael, Klingebiel, Thomas, Bader, Peter, Huenecke, Sabine, Rettinger, Eva
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554420/
https://ncbi.nlm.nih.gov/pubmed/31214182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01218
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki